Astec Lifesciences Price Movement Clarification
Astec LifeSciences clarified to NSE that recent volume spurts are market-driven with no undisclosed developments. The company maintains full compliance with all SEBI disclosure regulations.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
35 announcements with these filters
Astec LifeSciences clarified to NSE that recent volume spurts are market-driven with no undisclosed developments. The company maintains full compliance with all SEBI disclosure regulations.
Astec LifeSciences submitted its Annual Secretarial Compliance Report for the financial year ended March 2026. The report details regulatory compliance status and past governance observations.
Astec LifeSciences Limited confirmed the timely redemption of ₹25 Crore worth of Commercial Papers. The payment was made upon maturity on May 22, 2026.
Astec LifeSciences notified shareholders regarding the mandatory transfer of unclaimed dividends and shares to the IEPF. This routine regulatory compliance follows the seven-year non-claim threshold.
Astec LifeSciences fixed June 2026 record dates for redeeming four Commercial Paper series. Investors should track these dates to ensure timely receipt of maturity payments.